Clinical Trials Logo
  1. Home
  2. Induced Abortion
  3. NCT04242212

Study of Clinic-based vs. Self-use of a Misoprostol-only Regimen for Induced Abortion

Induced Abortion Clinical Trial

Official title:
A Prospective, Comparative Study of Clinical Outcomes Following Clinic-based Versus Self-use of Medication Abortion Using a Misoprostol-only Regimen

Clinical Trial Summary

The goal of the study is to determine whether important clinical outcomes differ among women who access a misoprostol-only medication abortion regimen from a patent medicine vendor when compared with those who access it from a clinic.

Clinical Trial Description

Medication abortion with a misoprostol-only regimen within the first 10 weeks of pregnancy is safe and effective. Investigators aim to assess whether self-use of early (<9 weeks) medication abortion using a misoprostol-only regimen results in non-inferior rates of clinical outcomes when compared with clinic-based provision of medication abortion.

The investigators will prospectively recruit women who obtain misoprostol from patent medicine vendors and clinics. Follow-up will occur by telephone during three phone calls within 45 days of the first dose of misoprostol. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04242212
Study type Observational
Source Ipas
Contact Kristen M Shellenberg, PhD, MPH
Phone 1.310.733.6524
Email shellenbergk@ipas.org
Status Recruiting
Phase
Start date May 19, 2019
Completion date June 30, 2020
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02208596 - The Feasibility of Different Doses of Etomidate Admixed With Propofol in Induced Abortion: A Randomized, Double Blind Controlled Trial Phase 4
Completed NCT02412618 - Same-Day Mifepristone-Misoprostol Compared to Misoprostol Only for Surgical Abortion Cervical Preparation Phase 4
Completed NCT01842100 - To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy N/A
Completed NCT00540748 - Is Oxytocin Given During Surgical Procedure for Abortion Before 12 Weeks of Pregnancy Useful? N/A
Completed NCT03727308 - Study of Clinic-based Versus Self-use of Medical Abortion Pills
Completed NCT00482209 - Study of 400mcg Versus 800mcg Buccal Misoprostol Following Mifepristone 200mg for Abortion up to 63 Days Gestation N/A
Completed NCT00621543 - Insertion of an Intrauterine Device (IUD) After Medical Abortion N/A
Recruiting NCT01636063 - Mifepristone Versus Misoprostol for Cervical Preparation Prior to Surgical Abortion Between 11 to 15 Weeks N/A
Completed NCT01173003 - Expansion Study of a Simplified Regimen of Medical Abortion Thru 63 Last Menstrual Period (LMP) in Tunisia N/A
Completed NCT05532085 - Assessment of Pain During an Abortion With Knowledge of the Predictive Factors of Pain.
Terminated NCT01776957 - Post Abortion IUD & Recurrent Abortion 2005-2006
Completed NCT01047748 - A Trial of Digoxin Before Second-Trimester Abortion N/A
Completed NCT00401440 - Comparison of Two Regimens of Misoprostol for Second Trimester Medical Termination of Pregnancy Phase 4
Completed NCT00619658 - The Feasibility of Simplified Telephone Follow-up After Medical Abortion N/A
Completed NCT00324519 - Randomized Trial Comparing Misoprostol and Foley Bulb for Pregnancy Termination in the Second Trimester Phase 4
Completed NCT04181541 - Midlevel Versus Physician-provided Medical Abortion in the Second Trimester N/A
Completed NCT00286208 - Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days Gestation N/A
Completed NCT01085825 - Study of the Sensitivity of Manual vs Electric Aspiration to Detect Completed Early Abortion N/A